Abstract 6941: Bi- and tri-specific ADCs that target two distinct growth factor receptor forms of MUC1* and HER2 or alpha-v-beta-6 inhibit tumor recurrence and overcome acquired resistance
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Cynthia Carol Bamdad, Benoit J. Smagghe, Scott Moe, Mark G. Carter, Kevin R. Yi, Michael J. Nash, Robert McDermott, Trevor J. Grant, Salvatore Marchese, Daniel S. Miller, Natalie K. Miller, Andrew K. Stewart
Institution: Minerva Biotechnologies (United States)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148709158
Cites:
Cited by:
Related to: